Source: Virtual Congress 2020 – Inflammatory pathways in chronic airway diseases
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
S. Behrend (Munich, Germany), M. Spella (Rio, Greece), M. Pepe (Munich, Germany), M. Lianou (Rio, Greece), I. Giopanou (Rio, Greece), G. Stathopoulos (Munich, Germany). Mapping of KRAS mutations during chemical carcinogenesis. 918

Member's Comments

BEN KALS - 05.12.2023 17:02
I was checking about new developments genital herpes virus then i saw how different persons talks about getting cured from herpes through a particular herbalist called Timothy so decided i Contacted him through his website https://5dc41d5b6d60d.site123.me and he responded with instructions about what he needs to prepare the herbal medication which i did and he sent the herbal meds to me in LA and after drinking the herbal medicine as he instructed i went back to the hospital few months later and the test result shows I'm negative after all the blister symptoms were gone and now I'm completely free of genital Herpes thanks to Dr.Timothy for his medication.

Related content which might interest you: PP134 – Mapping of Kras mutations during chemical carcinogenesis Source: ERS Lung Science Conference 2021 Year: 2021 Mapping of Kras mutations during chemical carcinogenesis Source: Virtual Congress 2021 – Novel insights into the pathogenesis of chronic lung diseases Year: 2021 LSC - 2021 - Mapping of Kras mutations during chemical carcinogenesis Source: Virtual Congress 2021 – Biology of lung cancer: preclinical and translational research Year: 2021 Are KRAS mutations druggable? Source: New biomarkers, molecules and therapeutic sequences for non small cell lung carcinoma in the era of precision medicine Year: 2019 KRAS & TP53 mutations cause malignant mesothelioma Source: ERS Lung Science Conference 2017 Year: 2017 Mutation of TP53 and KRAS, and loss of p16ink4a and p14arf expression in lung cancers in relation to tobacco smoke Source: Eur Respir J 2005; 26: Suppl. 49, 93s Year: 2005 Target other gene point mutations: HER2 and rare EGFR mutations Source: ERS Research Seminar Year: 2015 Prognostic value of TP53, KRAS and EGFR mutations in nonsmall cell lung cancer: the EUELC cohort Source: Eur Respir J 2012; 40: 177-184 Year: 2012 Germ-line exon 21 EGFR mutations, V843I and P848L, in nonsmall cell lung cancer patients Source: Eur Respir Rev 2014; 23: 390-392 Year: 2014 p53 gene mutations in lung cancer in Korean Source: Eur Respir J 2005; 26: Suppl. 49, 327s Year: 2005 Frequency and clinical-tomographic characterization of NSCLC with T790M mutation to TKI progression. Source: International Congress 2019 – Diagnosis of lung cancer Year: 2019 LSC - 2017 - KRAS & TP53 mutations cause malignant mesothelioma Source: International Congress 2017 – Pleural disease and mesothelioma: from the bench to the bedside Year: 2017 NKX2-1 impacts prognosis in early stage NSCLC not harboring TP53 mutations Source: International Congress 2016 – Prognostic variables in lung cancer I Year: 2016 Detection of k-ras codon 12 mutations in human lung tumour tissue by REMS-PCR Source: Eur Respir J 2001; 18: Suppl. 33, 233s Year: 2001 The analysis of CHEK2 gene mutation in small cell lung cancer Source: Virtual Congress 2021 – Novel insights into the pathogenesis of chronic lung diseases Year: 2021 EGFR, KRAS, BRAF and ALK gene alterations in lung adenocarcinomas: patient outcome, interplay with morphology and immunophenotype Source: Eur Respir J 2014; 43: 872-883 Year: 2014 Evaluation of EGFR mutations and ERCC2 polymorphisms in treatment of non-small cell lung cancer Source: Annual Congress 2005 - Chemotherapy and palliative care Year: 2005 Oncogenic potential of MET SEMA mutations affecting brain metastases from NSCLC is sustained by their microrheological features Source: International Congress 2017 – Basic research in lung cancer: a scientific potpourri from genetic alterations to immune cells Year: 2017 EGFR, KRAS, HER2, BRAF and PI3KCA mutation status in metastatic cancer patients: Thoracic cytological specimens obtained in routine clinical practice Source: Annual Congress 2013 –Progress in bronchoscopy and pathology techniques for diagnosis of thoracic malignancies Year: 2013 Sotorasib for Lung Cancers with KRAS p.G12C Mutation Source: Journal Club 2022 Year: 2022